Trials / Completed
CompletedNCT01363453
User Surveillance in Ulcerative Colitis
Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when and how long steroids are given.
Conditions
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-05-01
- Completion
- 2008-07-01
- First posted
- 2011-06-01
- Last updated
- 2011-06-01
Locations
105 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01363453. Inclusion in this directory is not an endorsement.